FDA Inspection 1004521 — National Genetics Institute

National Genetics Institute — FEI 3003082450

The FDA completed an inspection of National Genetics Institute on January 19, 2017 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 19, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)